Showing results (231-240 of 1,519) with videos related to
Sort By:
Pageof 152
Molecular Biology of the Cell|July 10, 2009
Divergent S phase checkpoint activation arising from prereplicative complex deficiency controls cell survivalEric Lau, Gary G Chiang, Robert T Abraham, et al.Journal of Cardiovascular Electrophysiology|September 15, 2004
Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patientsBruce L Wilkoff, Mike Hess, James Young, et al.American Heart Journal|January 31, 2006
Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) studyCecilia Linde, Michael Gold, William T Abraham, et al.Congestive Heart Failure (Greenwich, Conn.)|April 11, 2008
Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) studyCecilia Linde, Michael Gold, William T Abraham, et al.The Journal of Allergy and Clinical Immunology|December 1, 1994
Tyrosine phosphorylation and inositol phosphate production: are early events in human eosinophil activation stimulated by immobilized secretory IgA and IgG?H Kita, M Kato, G J Gleich, et al.Cell Cycle (Georgetown, Tex.)|November 11, 2009
Targeting mTOR globally in cancer: thinking beyond rapamycinBoris Shor, James J Gibbons, Robert T Abraham, et al.Journal of the American College of Cardiology|November 20, 2010
Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) studyCecilia Linde, William T Abraham, Michael R Gold, et al.The Journal of Biological Chemistry|November 25, 1990
Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporineJ P Secrist, I Sehgal, G Powis, et al.Chest|May 4, 2019
Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSAShahrokh Javaheri, Lee K Brown, William T Abraham, et al.Clinical Cardiology|March 1, 1983
Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary diseaseP E Fenster, F M Hasan, T Abraham, et al.Pageof 152